TLX Stock Analysis: Talanx | XETRA
Insurance - Diversified | XETRA, Germany | Market Cap: 27.992m EUR | 12M Return: 4% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 13.5M
EPS Trend: 92.7%
Rev. Trend: 41.8%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 10.5 years of data
Average return per month, with how dependable it is below — did the month move the same way every year (high) or randomly (low). Above 60 is a pattern worth trusting; under 40 is noise.
Talanx AG is a Germany-based multi-line insurance and reinsurance company offering a broad range of life and non-life products, including motor, property, casualty, health, aviation, marine, credit and surety, and cyber coverage. It also operates bancassurance, structured and facultative reinsurance, nat cat and asset management activities, and distributes through both standard and customized offerings. The groups portfolio spans multiple insurance lines, which is characteristic of multi-line carriers that diversify earnings across life and property-and-casualty segments.
The company distributes its products globally, with operations across Germany, the United Kingdom, Türkiye, Central and Eastern Europe, the wider European region, the United States, Latin America, Asia, Australia, and Africa. Founded in 1903 and headquartered in Hanover, Talanx is a subsidiary of HDI Haftpflichtverband der Deutschen Industrie V.a.G., a mutual liability association (Versicherungsverein auf Gegenseitigkeit), a legal form in the German insurance market in which policyholders hold membership rights in the parent entity.
- Hannover Re nat cat claims and treaty pricing drive group earnings
- Higher interest rates lift investment income on insurance reserves
- International and specialty insurance growth expands premium base
| Net Income: 2.65b TTM > 0 and > 6% of Revenue |
| FCF/TA: 43.10 > 0.02 and ΔFCF/TA 4.31k > 1.0 |
| NWC/Revenue: 0.02% < 20% (prev 33.37%; Δ -33.36% < -1%) |
| CFO/TA 45.58 > 3% & CFO 8.37b > Net Income 2.65b |
| Net Debt (3.58b) to EBITDA (5.55b): 0.65 < 3 |
| Current Ratio: error (cannot be calculated; needs correct Total Current Assets and Liabilities) |
| Outstanding Shares: last quarter (258.2m) vs 12m ago 0.00% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 59.28% > 50% (prev 13.58%; Δ 45.70% > 0%) |
| Interest Coverage Ratio: 22.82 > 6 (EBIT TTM 5.41b / Interest Expense TTM 237.0m) |
| A: 0.05 (Total Current Assets 8.50m - Total Current Liabilities 0.0) / Total Assets 183.7m |
| B: 67.22 (Retained Earnings 12.3b / Total Assets 183.7m) |
| C: 0.06 (EBIT TTM 5.41b / Avg Total Assets 90.3b) |
| D: 0.09 (Book Value of Equity 14.3m / Total Liabilities 161.5m) |
| Altman-Z'' = 219.9 = AAA |
| DSRI: 0.10 (Receivables 8.50m/1.22b, Revenue 53.6b/24.5b) |
| GMI: 1.0 (GM 100.0% / 100.0%) |
| AQI: -4.07 (AQ_t -3.83 / AQ_t-1 0.94) |
| SGI: 2.19 (Revenue 53.6b / 24.5b) |
| TATA: -31.16 (NI 2.65b - CFO 8.37b) / TA 183.7m) |
| Beneish M = -9.25 (Cap -4..+1) = AAA |
As of July 01, 2026, the stock is trading at EUR 110.60 with a total of 109,563 shares traded. Over the past week, the price has changed by +3.75%, over one month by +8.22%, over three months by +8.27% and over the past year by +4.03%.
Current recommended Stop Loss: 105.30 (which is 4.8% or 2.7 ATR below the current price).
Talanx has no consensus analysts rating.
P/E Trailing = 10.5756
P/E Forward = 10.1215
P/S = 0.6162
P/B = 1.9575
P/EG = 33.7379
Revenue TTM = 53.6b EUR
EBIT TTM = 5.41b EUR
EBITDA TTM = 5.55b EUR
Long Term Debt = 7.90b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 1.73b EUR (from shortTermDebt, last fiscal year)
Debt = 8.84b EUR (from shortLongTermDebtTotal, last fiscal year) + Leases 367.0m
Net Debt = 3.58b EUR (calculated: Debt 8.84b - CCE 5.26b)
Enterprise Value = 31.6b EUR (28.0b + Debt 8.84b - CCE 5.26b)
Interest Coverage Ratio = 22.82 (Ebit TTM 5.41b / Interest Expense TTM 237.0m)
EV/FCF = 3.99x (Enterprise Value 31.6b / FCF TTM 7.92b)
FCF Yield = 25.08% (FCF TTM 7.92b / Enterprise Value 31.6b)
FCF Margin = 14.78% (FCF TTM 7.92b / Revenue TTM 53.6b)
Net Margin = 4.95% (Net Income TTM 2.65b / Revenue TTM 53.6b)
Gross Margin = unknown ((Revenue TTM 53.6b - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = 171.9 (set to none) (Enterprise Value 31.6b / Total Assets 183.7m)
Interest Expense / Debt = 2.68% (Interest Expense 237.0m / Debt 8.84b)
Taxrate = 22.93% (1.24b / 5.41b)
NOPAT = 4.17b (EBIT 5.41b * (1 - 22.93%))
Current Ratio = unknown (Total Current Assets 8.50m / Total Current Liabilities 0.0)
Debt / Equity = 618.4 (Debt 8.84b / totalStockholderEquity, last quarter 14.3m)
Debt / EBITDA = 0.65 (Net Debt 3.58b / EBITDA 5.55b)
Debt / FCF = 0.45 (Net Debt 3.58b / FCF TTM 7.92b)
Total Stockholder Equity = 9.51b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.93% (Net Income 2.65b / Total Assets 183.7m)
RoE = 27.86% (Net Income TTM 2.65b / Total Stockholder Equity 9.51b)
RoCE = 31.07% (EBIT 5.41b / Capital Employed (Equity 9.51b + L.T.Debt 7.90b))
RoIC = -106.5% (out of range, set to none) (EBIT 5.41b / (Assets 183.7m - Curr.Liab 0.0 - Cash 5.26b))
WACC = 6.06% (E(28.0b)/V(36.8b) * Re(7.32%) + D(8.84b)/V(36.8b) * Rd(2.68%) * (1-Tc(0.23)))
Discount Rate = 7.32% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 14.91 | Cagr: 0.0%
[DCF] Terminal Value 74.57% ; FCFF base≈8.12b ; Y1≈7.74b ; Y5≈7.39b
[DCF] Fair Price = 436.1 (EV 116b - Net Debt 3.58b = Equity 113b / Shares 258.2m; r=8.35% [WACC [floored]]; 5y FCF grow -6.08% → 2.50% )
EPS Correlation: 92.73 | EPS CAGR: 18.43% | SUE: N/A | # QB: 0
Revenue Correlation: 41.80 | Revenue CAGR: 21.90% | SUE: 0.03 | # QB: 0
EPS current Year (2026-12-31): EPS=10.78 | Chg30d=+0.43% | Revisions=+50% | GrowthEPS=+12.3% | GrowthRev=+5.5%
EPS next Year (2027-12-31): EPS=11.15 | Chg30d=+0.98% | Revisions=+0% | GrowthEPS=+3.4% | GrowthRev=+4.5%
[Analyst] Revisions Ratio: +50%